Skip to Content

WATSON 240 0.5 (Lorazepam 0.5 mg)

Pill with imprint WATSON 240 0.5 is White, Round and has been identified as Lorazepam 0.5 mg. It is supplied by Watson Laboratories, Inc..

Lorazepam is used in the treatment of anxiety; insomnia; cervical dystonia; borderline personality disorder; panic disorder (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines, miscellaneous antiemetics. There is positive evidence of human fetal risk during pregnancy. Lorazepam 0.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 240 0.5

Lorazepam 0.5 mg WATSON 240 0.5
Lorazepam 0.5 mg WATSON 240 0.5 Front
Lorazepam 0.5 mg WATSON 240 0.5 Back
Lorazepam 0.5 mg WATSON 240 0.5


WATSON 240 0.5
0.5 mg
6.00 mm
Prescription only
Drug Class:
Benzodiazepine anticonvulsants
Miscellaneous antiemetics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
4 - Some potential for abuse
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
polacrilin potassium
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
63739-0499 McKesson Packaging Services
66267-0133 Nucare Pharmaceuticals Inc. (repackager)
43063-0057 PDRX Pharmaceuticals Inc. (repackager)
55289-0402 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.